Misfolded immunoglobulin light chain (AL amyloid)
Assets acting on this target.
- Class
- Anti-misfolded light chain antibody (amyloid depleter)
Assets acting on this target.
1 of 1 assets (1 discontinued)
| Drug | Owner | Mechanism | Indication | Reached | Why it stopped | Source |
|---|---|---|---|---|---|---|
| birtamimab | Prothena Biosciences Limited | Misfolded immunoglobulin light chain (AL amyloid) | AL Amyloidosis | Ph 3 | Company-directed Phase 3 disclosed in PRTA 10-K (2026-02-27) | source ↗ |